Ian Anderson

Ian Anderson, PhD, has served as Executive Vice President, Translational R&D since April 2022. Ian has over 30 years of experience in the pharmaceutical and biotechnology industry, and most recently held the position of Chief Scientific Officer for Flame Biosciences. Prior to this Ian was Senior Vice President Immunology Discovery & Scientific Innovation for Janssen Pharmaceuticals. Ian led Respiratory and Inflammation and Autoimmune Discovery at MedImmune, and preceding this he was Vice President Research at Cambridge Antibody Technology. Ian started his career at Glaxo Group Research.

Throughout his career, Ian led the advancement of small molecule and antibody drug projects from early discovery through phase 1 and 2 clinical development. He has experience across therapeutics areas including respiratory and autoimmune, CNS and oncology. Ian has published over 50 peer-reviewed publications.

Ian received his Pharmacology BSc from Manchester University and Doctor of Philosophy from University College London.